Claire Vivo
-
- Cancer-related Molecular Pathways 4
- Cancer Cells and Metastasis 2
- Cytokine Signaling Pathways and Interactions 1
-
- Cancer Research and Treatments 3
-
- Cell death mechanisms and regulation 2
-
- Occupational and environmental lung diseases 6
-
- Toxin Mechanisms and Immunotoxins 1
-
- Herpesvirus Infections and Treatments 1
- Co-authors
- Eugenia V. BroudeV. Courtney BroaddusMarie‐Claude JaurandWeihong LiuMikhail V. BlagosklonnyMari E. SwiftZoya N. DemidenkoBrian M. Davis
- Journals
- Journal of Biological Chemistry (1 paper)Oncogene (2 papers)British Journal of Cancer (1 paper)
- Partner nations
- United StatesFranceFinland
In The Last Decade
Claire Vivo
12 papers receiving 390 citations
Peers
Comparison fields: 5 of 68
- Oncology 164
- Biotechnology 44
- Molecular Biology 231
- Pulmonary and Respiratory Medicine 107
- Cancer Research 45
Countries citing papers authored by Claire Vivo
This map shows the geographic impact of Claire Vivo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Vivo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Vivo more than expected).
Fields of papers citing papers by Claire Vivo
This network shows the impact of papers produced by Claire Vivo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Vivo. The network helps show where Claire Vivo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Claire Vivo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 67 | |
| 2 | 2007 | 32 | |
| 3 | 2007 | 50 | |
| 4 | 2005 | 64 | |
| 5 | 2004 | 7 | |
| 6 | 2003 | 12 | |
| 7 | 2003 | 52 | |
| 8 | 2001 | 27 | |
| 9 | Concurrent herpes simplex type 1 and varicella-zoster in the V2 dermatome in an immunocompetent patient. | 2001 | 5 |
| 10 | 2000 | 19 | |
| 11 | Human malignant mesothelioma cell growth: activation of janus kinase 2 and signal transducer and activator of transcription 1alpha for inhibition by interferon-gamma. | 1998 | 31 |
| 12 | 1997 | 30 |
About Claire Vivo
Claire Vivo is a scholar working on Biotechnology, Oncology and Pulmonary and Respiratory Medicine, having authored 12 papers that have together received 396 indexed citations. Recurring topics across this work include Occupational and environmental lung diseases (6 papers), Cancer-related Molecular Pathways (4 papers), Cancer Research and Treatments (3 papers), Cell death mechanisms and regulation (2 papers), Cancer Cells and Metastasis (2 papers), Cytokine Signaling Pathways and Interactions (1 paper), Toxin Mechanisms and Immunotoxins (1 paper) and Herpesvirus Infections and Treatments (1 paper). The work is most often cited by research in Oncology (164 citations), Biotechnology (44 citations) and Molecular Biology (231 citations). Claire Vivo has collaborated with scholars based in United States, France and Finland. Frequent co-authors include Eugenia V. Broude, V. Courtney Broaddus, Marie‐Claude Jaurand, Weihong Liu, Mikhail V. Blagosklonny, Mari E. Swift, Zoya N. Demidenko, Brian M. Davis, Igor B. Roninson and Yannick Pilatte. Their work appears in journals such as Journal of Biological Chemistry, Oncogene and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.